Hepatitis
Conference Coverage
Hepatitis C falls as barrier to heart transplantation
GRAPEVINE, TEXAS – Transplant recipients, whether naive or previously exposed to HCV, eradicated the virus with direct-acting antiviral therapy....
From the Journals
Burden of HCV-induced cirrhosis expected to shift from men to women
Investigators expect women to become the main burden of HCV care.
From the Journals
Light alcohol use did not affect liver fibrosis progression in HIV/HCV-coinfected women
Women coinfected with HIV and HCV who drank light and moderate amounts of alcohol did not experience significant progression of liver fibrosis.
From the Journals
AAP recommends hepatitis B vaccine within 24 hours of birth for all infants
The safety net of the birth dose is critically important.
News from the FDA/CDC
FDA approves faster, pangenotypic cure for hep C virus
A faster cure for all genotypes of the hepatitis C virus with or without liver disease comes to market.
News
FDA advisory panel backs safety of new hepatitis B vaccine for adults
A new, two-dose hepatitis B vaccine is given the nod of approval for further study.
News
FDA approves new treatment for adults with HCV
Results of two trials showed that 96%-97% of patients who received Vosevi had no virus detected in the blood 12 weeks after finishing treatment
From the Journals
Liver cancer risk lower after sustained response to DAAs
DAAs may reduce prevalence of hepatocellular carcinoma among patients with hepatitis C.
From the Journals
Hexavalent hepatitis B vaccination mostly immunogenic 10 years later
Vaccine success mostly persists at 10 years.
Opinion
Hepatitis C is a pediatric disease now
The baby looked perfect: healthy term male, weight at the 60th percentile, normal exam. The mother, a 26-year-old diagnosed with hepatitis C virus...
News
ACIP approves new hepatitis A vaccine draft recommendations
New recommendations from ACIP target susceptible hepatitis A populations.